Viewing Study NCT05773092


Ignite Creation Date: 2025-12-24 @ 3:14 PM
Ignite Modification Date: 2025-12-25 @ 1:37 PM
Study NCT ID: NCT05773092
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-03
First Post: 2023-03-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC
Sponsor: National Cancer Centre, Singapore
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module